This inventor holds 45 USPTO granted patents and 12 published patent applications, plus 9 CIPO patents and 15 EPO patents, primarily in Poly-N-Acetylglucosamine. Top assignees: Marine Polymer Technologies, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Marine Polymers Technologies. Active years: 1997-2020.
Location History:
- Hanover, NH (US) (1997 - 2005)
- Somerville, MA (US) (2007 - 2014)
- Charleston, SC (US) (2000 - 2020)
Company Filing History:
38 out of 39 
3 out of 3,690 
2 out of 2 
Years Active: 1997-2020
Areas of Expertise:
Title: John N Vournakis: Pioneering Innovations in Nanofiber Technology
Introduction
John N Vournakis is a distinguished inventor based in Hanover, NH, recognized for his groundbreaking work in the field of nanotechnology. With an impressive portfolio of 45 patents, his contributions have significantly advanced the treatment of various diseases through innovative materials.
Latest Patents
Vournakis's latest patents include a pioneering application titled "Treatment of disease with poly-N-acetylglucosamine nanofibers." This invention focuses on compositions comprising shortened fibers of poly-N-acetylglucosamine, also known as sNAG nanofibers, which are utilized in disease treatments. Another recent patent, "Anti-bacterial applications of poly-N-acetylglucosamine nanofibers," details the use of these fibers in combatting bacterial infections. The compositions developed can be formulated for both the prevention and treatment of diseases associated with bacterial infections.
Career Highlights
Throughout his career, John N Vournakis has made substantial contributions while working with reputable companies, including Marine Polymer Technologies, Inc. and Marine Polymers Technologies. His work has consistently focused on harnessing the potential of nanofiber technology, pushing the boundaries of innovation in medical treatments.
Collaborations
Collaboration has been a key component of Vournakis's successful career. He has worked alongside notable individuals such as Sergio Finkielsztein and Ernest R Pariser, enriching the research and development efforts in the fields of biotechnology and nanotechnology.
Conclusion
John N Vournakis stands as a prominent figure in the realm of innovation, exemplifying how dedicated research and inventive thinking can lead to significant advancements in medical science. His ongoing work promises to contribute further to the future of disease treatment through innovative materials and applications.